Winchester, United Kingdom
February 24, 2015
Exosect Ltd, a leading provider of enabling technologies, has been granted a patent in Canada for seed treatment for oilseeds, using its proprietary technology platform, Entostat.
Entostat is an electrostatic, dry micro-powder, based on natural and/or synthetic waxes which readily adheres to the seed surface. Entostat is an effective delivery platform for a wide range of active ingredients including synthetic chemicals, biopesticides and bio-stimulants. The benefit of this bio-stimulant seed treatment (formulation contains spores of the saprophytic fungus, Penicillium bilaii) is in the improved root growth and greater protection from environmental stresses. Compared to conventionally treated seed it requires less additives, particularly inorganic fertilisers, than that required by conventional farming techniques.
Martin Brown, Exosect’s CEO comments “Together with the patent we received earlier this month in the UK & Canada for improved seed flowability and dust drift reduction, also using the Entostat platform, we are able to offer partners the Entostat platform to develop seed treatment formulations with significant and unique attributes for the oilseed sector.”
BACKGROUND
Entostat is an electrostatically charged micro-powder. A leading variant of Entostat is based on a carnauba wax blend that is chemically inert. This variant of Entostat is sustainably harvested from the Brazilian Carnauba palm, Copernica martius (Palmae). Other variants include a range of natural and synthetic waxes and polymers.
Entostat is a non-hygroscopic electrostatic micro-powder that can be produced in a range of sizes and shapes. It can be formulated to microencapsulate synthetic active ingredients offering release retardation and to support biological active ingredients on its surface by electrostatic attraction.
Entostat readily gains an electrostatic charge, consequently it adheres to a range of surfaces including, grains and seeds, insects and animals, and building fabric.
It is proven to deliver active ingredients at a reduced application rate with equivalent or improved efficacy.
About Exosect
Exosect was launched in 2001 to develop proprietary platforms technologies, initially for agriculture.
The company has developed an in-depth knowledge and extensive patent portfolio of the platforms as targeted delivery mechanisms for a range of active ingredients, biological and synthetic.
Today, the technology is enabling our partners across a range of sectors to realise the efficient delivery of their active ingredients, helping them to overcome issues such as pest resistance, regulatory controls and residues within the food chain.
Exosect is focussed on the Agriculture, Public Health and Animal Health sectors.
Topics
Species
